Nordson Corporation reported fiscal 2025 fourth‑quarter revenue of $752 million, up 1% from $744 million a year earlier, and net income of $152 million, translating to $2.69 in diluted earnings per share. Adjusted earnings reached $171 million, or $3.03 per share, a 9% year‑over‑year increase that beat consensus estimates of $2.99 by $0.04. Full‑year 2025 sales totaled $2.8 billion, a 4% rise, while net income climbed to $484 million ($8.51 diluted EPS) and adjusted earnings hit $583 million ($10.24 EPS).
The company’s segment mix drove the results. Medical and Fluid Solutions grew 10% in sales, buoyed by strong demand in medical device and fluid handling markets, offsetting a 2% decline in Industrial Precision Solutions and a 4% drop in Advanced Technology Solutions. The industrial segment’s weakness stemmed from softness in polymer processing systems, while the advanced technology segment suffered from fewer deliveries of test and inspection systems. These headwinds were partially counterbalanced by favorable currency translation and acquisitions that added high‑margin revenue.
Margin performance underscored the company’s operational discipline. EBITDA rose to $900 million, representing 32% of sales, an improvement over the prior year’s 30% margin. Free cash flow reached a record $661 million, a 136% conversion of net income, reflecting disciplined cost management and a portfolio shift toward higher‑margin products. Gross margin increased to 56.3%, driven by pricing power in the medical segment and a higher mix of high‑margin contracts.
Guidance for fiscal 2026 signals confidence amid near‑term headwinds. Nordson projects full‑year sales between $2.830 billion and $2.950 billion and adjusted EPS between $10.80 and $11.50. First‑quarter guidance calls for sales of $630 million to $670 million and adjusted EPS of $2.25 to $2.45. Management highlighted the Ascend strategy and NBS Next framework as key growth engines, while noting softness in selected industrial and advanced technology product lines and the need to navigate macro‑economic uncertainty.
CEO Sundaram Nagarajan emphasized the company’s strategic focus: “The implementation of the Ascend Strategy, a combination of our NBS Next growth framework, owner mindset and winning teams, positions us well to meet increasing customer demand. We remain focused on creating value for our shareholders by deploying strategic capital for acquisitions, share repurchases, dividends and debt service.” He added that the company’s portfolio and balance‑sheet strength position it for continued growth as end markets inflect.
Analysts noted that Nordson’s EPS beat of $0.04, while revenue missed consensus estimates by $9–25 million, reflecting modest demand weakness in certain industrial segments. Investors reacted positively to the earnings beat and margin expansion, but the revenue miss and lower‑than‑expected Q1 guidance tempered enthusiasm. The company’s record cash flow and disciplined cost structure, however, reinforced confidence in its long‑term profitability.
The content on BeyondSPX is for informational purposes only and should not be construed as financial or investment advice. We are not financial advisors. Consult with a qualified professional before making any investment decisions. Any actions you take based on information from this site are solely at your own risk.